NMC Competitors

Delisted . USA . 
Stock . NMC Health PLC
NMHLYDelisted Stock  USD 0.0002  0.00  0.00%   
NMC Health PLC competes with IMAC Holdings, P3 Health, and HCA Holdings; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Care Facilities industry. Analyzing NMC Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of NMC Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of NMC Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00030.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00020.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.000400
Details

NMC Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between NMC Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of NMC and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of NMC Health PLC does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
HCA
+ 0.87
PIII
HCA
+ 0.79
IONM
PIII
+ 0.74
IONM
PIII
+ 0.58
BACK
BACK
+ 0.56
VLXC
HCA
+ 0.47
VLXC
  
High negative correlations   
PIII
- 0.56
NUMIF
HCA
- 0.55
CANO
IONM
- 0.55
NUMIF
CANO
- 0.51
IONM
HCA
- 0.48
NUMIF
CANO
- 0.34
PIII

Risk-Adjusted Indicators

There is a big difference between NMC Pink Sheet performing well and NMC Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NMC Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

NMC Health Competitive Analysis

The better you understand NMC Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, NMC Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across NMC Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NMHLY VLXC NUMIF BACK IONM PIII CANO HCA
 0.00 
 0.0002 
NMC
 10.57 
 0.08 
Veltex
 3.45 
 0.03 
Numinus
 8.04 
 1.21 
IMAC
 13.33 
 0.68 
Assure
 5.26 
 0.20 
PIII
 2.84 
 1.37 
Cano
 2.05 
 303.62 
HCA
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Out of control
Slightly risky
Very steady
Extremely Dangerous
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Insignificant
Modest
Modest
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Above Average
Quite High
High
Dangerous
Above Average
Dangerous
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Strong Buy
Not Available
Buy
Not Available
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Cautious Hold
Cautious Hold
Not Rated
Strong Sell
Not Rated
Cautious Hold
Current Ratio
1.70 X
19.36 X
16.08 X
1.18 X
6.62 X
0.75 X
1.64 X
1.38 X
Net Asset
3.87 B
43.45 K
52.63 M
1.14 M
7.51 M
860.97 M
1.93 B
56.21 B
Profit Margin
0.11 %
0.08 %
N/A
N/A
N/A
(0.05) %
(0.19) %
0.09 %
EBITDA
469.13 M
9.03 M
(42.85 M)
(5.95 M)
(27.37 M)
(81.07 M)
(288.42 M)
12.72 B
Operating Margin
0.18 %
0.08 %
(2.63) %
N/A
(486.33) %
(0.08) %
(0.12) %
0.14 %
Current Valuation
20.87 K
38.05 M
20.07 M
2.37 M
15.58 M
112.58 M
1.07 B
118.91 B
Price To Book
0.03 X
N/A
1.31 X
0.54 X
0.24 X
0.26 X
1.55 X
293.44 X
Current Asset
604.26 M
N/A
N/A
N/A
N/A
N/A
N/A
9.23 B
Retained Earnings
N/A
N/A
N/A
(55.94 M)
(70.63 M)
(367.34 M)
(286.03 M)
(1.35 B)
Beta
3199.39
0.29
2.03
0.26
1.74
1.14
0.053
1.69
Number Of Employees
17.75 K
3
10
2
95
400
4.01 K
220 K
Shares Outstanding
208.7 M
79.48 M
262.75 M
1.89 M
589.02 K
162.86 M
2.89 M
253.3 M
Cash Flow From Operations
387.82 M
(126.92 K)
(26.23 M)
(2.79 M)
(4.94 M)
(76.03 M)
(146.84 M)
9.43 B
Annual Yield
0.53 %
N/A
N/A
N/A
N/A
N/A
N/A
0.01 %
Total Debt
N/A
1.6 M
213.15 K
1.9 M
14.8 M
121.94 M
1.2 B
41.86 B
Return On Equity
0.19
0.12
-0.99
-3.32
-3.43
-0.41
-4.29
0.12
Return On Asset
0.0619
0.0699
-0.33
-0.38
-1.01
-0.12
-0.14
0.12
Book Value Per Share
6.68 X
N/A
0.14 X
(0.66) X
(40.23) X
1.22 X
(43.16) X
(8.57) X
Number Of Shares Shorted
N/A
N/A
N/A
32.15 K
2.91 M
818.01 K
577.29 K
3.53 M
Current Liabilities
402.34 M
N/A
N/A
N/A
N/A
N/A
N/A
5.52 B
Total Asset
3.87 B
43.45 K
52.63 M
1.14 M
7.51 M
860.97 M
1.93 B
56.21 B
Debt To Equity
1.66 %
0.03 %
0.12 %
0.35 %
0.64 %
0.08 %
1.42 %
N/A
Last Dividend Paid
0.23
N/A
N/A
N/A
N/A
N/A
N/A
2.58
Target Price
N/A
N/A
0.5
8.25
4.0
0.63
0.5
398.84
Short Ratio
N/A
N/A
N/A
1.22 X
0.31 X
1.21 X
2.03 X
2.28 X
Shares Owned By Institutions
0.09 %
N/A
2.88 %
3.10 %
2.13 %
24.98 %
34.33 %
63.62 %
Market Capitalization
417.41 K
23.37 M
49.17 M
2.28 M
1.43 M
109.58 M
12.43 M
76.91 B
Price To Earning
0.02 X
N/A
N/A
N/A
N/A
N/A
N/A
13.57 X
Price To Earnings To Growth
N/A
N/A
N/A
N/A
0.19 X
N/A
(0.05) X
0.98 X
Price To Sales
0.0003 X
0.50 X
6.38 X
86.44 X
0.51 X
0.08 X
0 X
1.10 X
Net Income
248.65 M
(1.84 M)
(44.88 M)
(9.42 M)
(21.45 M)
(57.77 M)
(577.76 M)
5.24 B
Earnings Per Share
0.01 X
N/A
(0.1) X
(5.81) X
(41.40) X
(0.86) X
(228.47) X
22.26 X
Shares Owned By Insiders
N/A
N/A
4.79 %
8.79 %
23.73 %
23.20 %
43.43 %
28.42 %
Revenue
2.06 B
N/A
6.49 M
5.2 M
255 K
1.27 B
3.1 B
64.97 B
Working Capital
201.92 M
N/A
N/A
(752.65 K)
(15.49 M)
(133.35 M)
132.31 M
2.27 B
Cash And Equivalents
574.15 M
1.01 M
41.79 M
1.61 M
792 K
63.15 M
24.1 M
908 M
Cash Per Share
2.75 X
N/A
0.17 X
0.06 X
0.06 X
1.52 X
0.10 X
3.97 X
Gross Profit
841.13 M
18.82 M
1.78 M
18.34 K
14.87 M
(7.75 M)
421.69 M
23.18 B
Day Typical Price
2.0E-4
0.0837
0.0307
1.22
0.65
0.2
1.37
301.73
Accumulation Distribution
N/A
N/A
0.23
0.15
0.12
0.14
0.0634
0.0271
Market Facilitation Index
N/A
N/A
0.008
0.2
0.08
0.03
0.09
8.27
Daily Balance Of Power
0.0
9.2 T
0.125
0.45
1.0
0.3333
(0.44)
0.7376
Period Momentum Indicator
N/A
0.008
0.001
0.09
0.08
0.01
(0.04)
6.1
Rate Of Daily Change
1.0
1.11
1.03
1.08
1.13
1.05
0.97
1.02
Day Median Price
2.0E-4
0.0837
0.031
1.22
0.64
0.2
1.38
300.78
Price Action Indicator
N/A
0.004
(0.0005)
0.035
0.08
0.01
(0.03)
5.89
Relative Strength Index
11.91
56.54
48.6
51.83
34.32
35.35
59.31
26.54
Coefficient Of Variation
(824.23)
(3,783)
1189.49
(5,692)
(639.77)
(888.42)
2002.09
(418.40)
Mean Deviation
4.1
3.52
8.0
3.58
10.52
5.1
4.54
1.13
Jensen Alpha
(1.53)
(0.22)
1.02
(0.11)
(2.86)
(0.93)
0.3418
(0.43)
Total Risk Alpha
(1.87)
(0.43)
0.6908
(0.23)
(3.19)
(1.12)
0.1289
(0.47)
Sortino Ratio
N/A
N/A
0.0854
N/A
N/A
N/A
0.0543
N/A
Downside Variance
N/A
N/A
142.39
N/A
N/A
N/A
27.34
N/A
Standard Deviation
12.49
7.63
12.5
4.79
17.23
7.93
6.33
1.72
Kurtosis
40.43
14.64
6.62
1.5
10.76
7.89
3.11
8.24
Potential Upside
N/A
11.25
20.0
8.11
17.24
9.52
11.11
2.05
Treynor Ratio
(17.29)
(1.11)
1.16
(0.10)
(0.39)
(0.75)
(0.19)
(1.76)
Maximum Drawdown
110.0
50.64
87.67
18.57
147.97
65.63
36.13
11.09
Variance
155.96
58.29
156.22
22.93
296.86
62.81
40.09
2.97
Market Risk Adjusted Performance
(17.28)
(1.10)
1.17
(0.09)
(0.38)
(0.74)
(0.18)
(1.75)
Risk Adjusted Performance
(0.09)
(0.01)
0.076
(0.01)
(0.11)
(0.08)
0.0483
(0.18)
Skewness
(5.77)
(2.50)
1.43
(0.38)
0.9866
(0.36)
1.15
(2.00)
Semi Deviation
N/A
N/A
9.23
N/A
N/A
N/A
4.7
N/A
Information Ratio
(0.12)
(0.03)
0.0815
(0.02)
(0.16)
(0.12)
0.0449
(0.26)
Value At Risk
N/A
(10.50)
(15.79)
(6.72)
(24.57)
(9.30)
(9.77)
(2.82)
Expected Short fall
N/A
N/A
(10.83)
N/A
N/A
N/A
(6.08)
N/A
Downside Deviation
N/A
N/A
11.93
N/A
N/A
N/A
5.23
N/A
Semi Variance
N/A
N/A
85.11
N/A
N/A
N/A
22.11
N/A

NMC Health Competition Performance Charts

Five steps to successful analysis of NMC Health Competition

NMC Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by NMC Health PLC in relation to its competition. NMC Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of NMC Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact NMC Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to NMC Health PLC, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your NMC Health position

In addition to having NMC Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run FinTech Thematic Idea Now

FinTech
FinTech Theme
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in NMC Pink Sheet

If you are still planning to invest in NMC Health PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NMC Health's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY